References
- Stossel TP. Regulating academic–industrial research relationships – solving problems or stifling progress? New Engl J Med 2005;353:1060–5
- Brennan TA, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. J Am Med Assoc 2006;295:429–33
- Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? J Am Med Assoc 2000;283:373–80
- Blumenthal D. Doctors and drug companies. New Engl J Med 2004;351:1885–90
- Davis M, Stark A. Conflict of interest in the health professions. Oxford: Oxford University Press; 2001. p. 27
- Kelch RP. Maintaining the public trust in clinical research. New Engl J Med 2002;346:285–7
- Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. New Engl J Med 2000;342:1539–44
- Angell M. Is academic medicine for sale? New Engl J Med 2000;342:1516–8
- DeAngelis C. Conflicts of interest and the public trust. J Am Med Assoc 2000;284:2237–8
- Mello MM, Clarridge BR, Studdert DM. Academic medical centers’ standards for clinical-trial agreements with industry. New Engl J Med 2005;352:2202–10
- Nathan DG, Weatherall DJ. Academic freedom in clinical research. New Engl J Med 2002;347:1368–71
- Johns MM, Barnes M, Florencio PS. Restoring balance to industry–academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. J Am Med Assoc 2003;289:741–6
- Cho MK, Shohara R, Schissel A, Rennie D. Policies on faculty conflicts of interest at US universities. J Am Med Assoc 2000;284:2203–8
- McCrary SV, Anderson CB, Jakovljevic J, et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. New Engl J Med 2000;343:1621–6
- Lo B, Wolf LE, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. New Engl J Med 2000;343:1616–20
- Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. J Am Med Assoc 2003;289:454–65
- Lurie P, et al. Financial conflict of interest disclosure and voting patterns at food and drug administration drug advisory committee meetings. J Am Med Assoc 2006; 295: 1921–9
- Eli Lilly & Company. Milestones in medical research. Available at http://www.lilly.com/about/milestones.html [accessed June 15, 2006]
- Gressor, M. Milestones in medicine. February 17, 2005 . Available at http://www.smh.com.au/articles/2005/02/17/1108500190027. html [accessed June 15, 2006]
- Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80: 827–41
- Blumenthal D. The future of the academic medical center under health care reform. New Engl J Med 1993;329:1812–4
- Pardes H. The perilous state of academic medicine. J Am Med Assoc 2000;283:2427–9
- Moses H, Braunwald E, Martin JB, Their SO. Collaborating with industry – choices for the academic medical center. J Am Med Assoc 2002;347:1371–5
- PhRMA code on interactions with health care professionals. Revised January 2004. Available at: http://www.phrma.org/publications/policy/2004–01–19.391.pdf [accessed February 1, 2005]
- Office of Inspector General. Compliance program guidance for pharmaceutical manufacturers. April 2003. Available at: http://oig.hhs.gov/fraud/docs/complianceguidance/042803pharmacymfgnonfr.pdf [accessed February 1, 2005]
- Accreditation Council for Continuing Medical Education. Standards for commercial support. Standards to ensure the independence of CME activities. Approved, September 2004. Available at: http://www.accme.org/dir_docs/doc_upload/68b2902a-fb73-44d1-8725-80a1504e520c_uploaddocument.pdf [accessed February 1, 2005]